These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32718985)

  • 1. Women's experiences of self-administration of misoprostol at home as part of early medical abortion: a qualitative evaluation.
    Harden J; Ancian J; Cameron S; Boydell N
    BMJ Sex Reprod Health; 2021 Apr; 47(2):144-149. PubMed ID: 32718985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women's experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic: a qualitative evaluation.
    Boydell N; Reynolds-Wright JJ; Cameron ST; Harden J
    BJOG; 2021 Oct; 128(11):1752-1761. PubMed ID: 34138505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-management of first trimester medical termination of pregnancy: a qualitative study of women's experiences.
    Purcell C; Cameron S; Lawton J; Glasier A; Harden J
    BJOG; 2017 Dec; 124(13):2001-2008. PubMed ID: 28421651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-depth interviews with medical abortion clients: thoughts on the method and home administration of misoprostol.
    Elul B; Pearlman E; Sorhaindo A; Simonds W; Westhoff C
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):169-72. PubMed ID: 10846331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Home self-administration of misoprostol for medical abortion up to 56 days' gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    J Fam Plann Reprod Health Care; 2005 Jul; 31(3):189-92. PubMed ID: 16105279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion.
    Kopp Kallner H; Fiala C; Gemzell-Danielsson K
    Contraception; 2012 Apr; 85(4):394-7. PubMed ID: 22067756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability and feasibility of medical abortion in Nepal.
    Karki C; Pokharel H; Kushwaha A; Manandhar D; Bracken H; Winikoff B
    Int J Gynaecol Obstet; 2009 Jul; 106(1):39-42. PubMed ID: 19345944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women's experiences of the final stage of early medical abortion at home: results of a pilot survey.
    Cameron S; Glasier A; Dewart H; Johnstone A
    J Fam Plann Reprod Health Care; 2010 Oct; 36(4):213-6. PubMed ID: 21067636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding a woman's options to include home use of misoprostol for medical abortion up until 76 days: an observational study of efficacy and safety.
    Larsson A; Ronnberg AM
    Acta Obstet Gynecol Scand; 2019 Jun; 98(6):747-752. PubMed ID: 30659579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choosing early pregnancy termination methods in Urban Mozambique.
    Mitchell EM; Kwizera A; Usta M; Gebreselassie H
    Soc Sci Med; 2010 Jul; 71(1):62-70. PubMed ID: 20452107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women's abortion seeking behavior under restrictive abortion laws in Mexico.
    Juarez F; Bankole A; Palma JL
    PLoS One; 2019; 14(12):e0226522. PubMed ID: 31881041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women's experiences with the use of medical abortion in a legally restricted context: the case of Argentina.
    Ramos S; Romero M; Aizenberg L
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):4-15. PubMed ID: 25702064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond the law: Misoprostol and medical abortion in Dar es Salaam, Tanzania.
    Solheim IH; Moland KM; Kahabuka C; Pembe AB; Blystad A
    Soc Sci Med; 2020 Jan; 245():112676. PubMed ID: 31810016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misoprostol alone--a new method of medical abortion?
    Blanchard K; Winikoff B; Coyaji K; Nguyen TN
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):189-90. PubMed ID: 10846336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to accessing abortion services and perspectives on using mifepristone and misoprostol at home in Great Britain.
    Aiken ARA; Guthrie KA; Schellekens M; Trussell J; Gomperts R
    Contraception; 2018 Feb; 97(2):177-183. PubMed ID: 28941978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy.
    Creinin MD; Vittinghoff E; Keder L; Darney PD; Tiller G
    Contraception; 1996 Jun; 53(6):321-7. PubMed ID: 8773418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Texas women's decisions and experiences regarding self-managed abortion.
    Fuentes L; Baum S; Keefe-Oates B; White K; Hopkins K; Potter J; Grossman D
    BMC Womens Health; 2020 Jan; 20(1):6. PubMed ID: 31906937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of hospital vs home self administration of vaginal misoprostol for medical abortion.
    Shrestha A; Sedhai LB
    Kathmandu Univ Med J (KUMJ); 2014; 12(47):185-9. PubMed ID: 25855109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.